Skip to search formSkip to main contentSkip to account menu

GL-ONC1

Known as: GLV-1h68 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
2012
2012
Purpose: Radiotherapy is part of the standard of care in high-grade gliomas but its outcomes remain poor. Integrating oncolytic… 
2011
2011
IntroductionOncolytic viruses show promise for treating cancer. However, to assess therapeutic efficacy and potential toxicity, a… 
Highly Cited
2009
Highly Cited
2009
We previously reported that the replication-competent vaccinia virus (VACV) GLV-1h68 shows remarkable oncolytic activity and… 
Highly Cited
2009
Highly Cited
2009
Oncolytic virotherapy of tumors has shown promising results in both preclinical and clinical studies. Here, we investigated the… 
2009
2009
Noninvasive and repetitive monitoring of a virus in target tissues and/or specific organs of the body is highly desirable for the… 
2009
2009
Mammary cancers together with cancers of the skin account for about 60% of the total cancers occurring in dogs. The veterinary… 
Highly Cited
2009
Highly Cited
2009
As a new anticancer treatment option, vaccinia virus (VACV) has shown remarkable antitumor activities (oncolysis) in preclinical… 
Highly Cited
2008
Highly Cited
2008
Malignant pleural mesothelioma (MPM) is a fatal disease with a median survival of less than 14 months. For the first time, a… 
Highly Cited
2007
Highly Cited
2007
Previously, we reported that a recombinant vaccinia virus (VACV) carrying a light-emitting fusion gene enters, replicates in, and…